Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/18/2025

Hormone-Related Disorders and Treatments

Introduction to Hormonal Influences

  • Normal physiological increase in progesterone levels during pregnancy, with levels rising 10-fold compared to non-pregnant state, as stated by the American Psychological Association 1
  • Thyroid disorders may alter hormone levels, including progesterone, according to the American Psychological Association 2

Contraception and Fertility Treatments

  • Oral contraceptives contain synthetic progestins that can affect progesterone levels, as stated by the American Association for the Study of Liver Diseases 3
  • Women with elevated progesterone due to certain conditions may require specialized care during pregnancy, and the American Association for the Study of Liver Diseases recommends careful planning 3
  • Women with conditions like acute hepatic porphyrias should avoid contraceptive methods involving only progesterone or progestins, as advised by the American Association for the Study of Liver Diseases 3

Diagnostic Testing for Hormonal Disorders

  • Elevated levels of 17-hydroxyprogesterone (17-OHP) >200 ng/dl, androstenedione above the upper limit of normal, and DHEAS >100 μg/dl are considered elevated and clinically significant in patients, according to The Journal of Urology guidelines 4
  • Normal range for 17-OHP is generally <50 nmol/L (or <200 ng/dl), as stated by the Annals of Oncology and The Journal of Urology guidelines 4, 5
  • Androstenedione levels are considered elevated when above the upper limit of normal, with clinical significance in conditions like PCOS, non-classical CAH, and adrenocortical tumors, as per the Annals of Oncology and The Journal of Urology guidelines 4, 5
  • The following table summarizes the diagnostic testing for hirsutism:
Test Indication
Testosterone (total and free) Initial testing
DHEAS Initial testing
17-hydroxyprogesterone Initial testing
LH/FSH ratio Initial testing
Morning cortisol and ACTH Clinical suspicion of Cushing syndrome
Prolactin levels Clinical suspicion of prolactinoma
Thyroid function tests Clinical suspicion of thyroid dysfunction
Fasting glucose and insulin Clinical suspicion of insulin resistance

Conditions Associated with Hormonal Imbalances

  • Adrenocortical tumors are characterized by elevated DHEAS (often >3800 ng/ml in younger women), elevated androstenedione, and variable 17-OHP levels, as indicated by the Annals of Oncology and The Journal of Urology guidelines 4, 5
  • Polycystic Ovary Syndrome (PCOS) is associated with mildly elevated androstenedione, mildly elevated DHEAS, and normal to slightly elevated 17-OHP, according to the Human Reproduction Update guidelines 6
  • Non-classical congenital adrenal hyperplasia (NCAH) is most commonly due to 21-hydroxylase deficiency, and is characterized by elevated 17-hydroxyprogesterone levels, modest elevation of testosterone, and may have elevated DHEAS levels 7
  • Cushing syndrome is a rare cause of hirsutism, associated with cortisol excess, central obesity, purple striae, buffalo hump, hypertension, hyperglycemia, and hypokalemia 8

Treatment and Management of Hormonal Disorders

  • Initial testing should include testosterone (total and free), DHEAS, 17-hydroxyprogesterone, and LH/FSH ratio (>2 suggests PCOS) 7
  • The American College of Obstetricians and Gynecologists recommends that clinicians identify the underlying cause of hirsutism and implement appropriate treatment strategies to address both cosmetic concerns and associated health risks 7
  • The American Academy of Family Physicians recommends assessing fasting glucose, insulin levels, and lipid profile in patients with hirsutism, particularly those with polycystic ovary syndrome (PCOS) and insulin resistance 9
  • Anti-androgens, such as spironolactone, flutamide, finasteride, and cyproterone acetate, can be used to treat hirsutism, with spironolactone being a common choice, dosed at 25-100 mg daily 9
  • The American Academy of Dermatology recommends combined oral contraceptives (COCs) as a first-line treatment for hyperandrogenism, which suppress ovarian androgen production, increase sex hormone-binding globulin (SHBG), and reduce free testosterone levels in women with hyperandrogenism 10
  • Lifestyle modifications, including weight loss if overweight or obese, regular exercise, and stress reduction, are recommended as part of the management plan for hyperandrogenism 10

Special Considerations and Precautions

  • Women with epilepsy have a higher prevalence of PCOS (10-25%) than the general population (4-6%) 7
  • The American Academy of Allergy and Clinical Immunology advises against the use of ACE inhibitors in patients with hyperandrogenism, as they may worsen the condition 11
  • The American Academy of Allergy and Clinical Immunology recommends discussing alternative treatments with women planning pregnancy, as androgens are contraindicated during pregnancy due to the risk of fetal virilization 11
  • Reducing hydrocortisone below 10mg total daily dose significantly increases the risk of adrenal crisis, as reported by the Journal of Internal Medicine 12
  • Discontinuing hydrocortisone despite side effects could be life-threatening, as warned by the Journal of Clinical Oncology 13
  • During illness, surgery, or significant physical stress, hydrocortisone dose should be increased, as recommended by the Journal of Clinical Oncology 13

REFERENCES

8

neuroendocrine tumors. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

10

guidelines of care for the management of acne vulgaris. [LINK]

Journal of the American Academy of Dermatology, 2024